Figure 1: Carboxyl-terminal modulator protein (CTMP) expression in head and neck squamous cell carcinoma (HNSCC) clinical specimens. | Scientific Reports

Figure 1: Carboxyl-terminal modulator protein (CTMP) expression in head and neck squamous cell carcinoma (HNSCC) clinical specimens.

From: Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation

Figure 1

(A) Immunohistochemical CTMP expression. Representative immunohistochemical images of: (a) no staining intensity, (b) weak staining intensity, (c) moderate staining intensity, and (d) strong staining intensity in tumor samples from 119 HNSCC patients. (a) and (b) were classified as ‘low CTMP expression’, whereas (c) and (d) were classified as ‘high CTMP expression’ (100x magnification). (B,C) CTMP expression levels in the total cell lysate acquired from normal (N)–tumor (T) paired clinical specimens were examined through (B) RT-PCR and (C) Western blot assays.

Back to article page